[Federal Register Volume 70, Number 234 (Wednesday, December 7, 2005)]
[Notices]
[Page 72844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23675]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Industry Exchange Workshop on Food and Drug Administration 
Clinical Trial Requirements; Public Workshop; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
amendment to the notice of public workshop on FDA clinical trial 
statutory and regulatory requirements. This workshop was announced in 
the Federal Register of September 21, 2005 (70 FR 55405). The amendment 
is made to reflect a change in the Location portion of the document. 
There are no other changes.

FOR FURTHER INFORMATION CONTACT:  David Arvelo, Food and Drug 
Administration, 4040 North Central Expressway, suite 900, Dallas TX 
75204, 214-253-4952, FAX: 214-253-4970, e-mail: [email protected].

SUPPLEMENTARY INFORMATION: In the Federal Register of September 21, 
2005 (70 FR 55405), FDA announced that a public workshop entitled 
``Industry Exchange Workshop on Food and Drug Administration Clinical 
Trial Requirements'' would be held on Wednesday, February 8, 2006. On 
page 55405, in the first column, the Location portion of the document 
is amended to read as follows:
    Location: The public workshop will be held at the Renaissance 
Houston Hotel Greenway Plaza, 6 Greenway Plaza East, Houston, TX 77046, 
713-629-1200, FAX: 713-629-4702.

    Dated: November 30, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05-23675 Filed 12-6-05; 8:45 am]
BILLING CODE 4160-01-S